Adriana Burgy

USPTO's First-Time Filer Expedited Examination Pilot Program

The USPTO's "Experimental Use Exception Request For Comments"

Inherently Obvious: What Is Happening?

Inherency Remains High Bar To Meet

Means-Plus-Function And Step-Plus-Function Claim Limitations (35 U.S.C. 112(f)): Memo To Examiners From The USPTO

Navigating The Nuances Of § 102(e): A Critical Look At State Designation In PCT Applications And Its Impact On Patent Litigation

Update On Subject Matter Eligibility In The U.S.

Update To USPTO Guidance For Determining Obviousness

Safe Harbor Protection: Acadia Pharms., Inc. v. Aurobindo Pharma Ltd.

Update On Diagnostic Claiming